J Clin Oncol 2020 Mar 02
Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?
Related Questions
Would you consider gem+Abraxane to avoid FOLFIRINOX toxicity in a small, node-negative tumor?
New comment by Medical Oncologist at Joliet Oncology Hematology Associates ( May 28, 2022)
I agree NAC should be given for pancreatic ca, however, in community practice, med onc involvement is after the fact. As a specialty, we need to push to educate our surg-onc a...